These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9377764)

  • 1. Preservation injury and donor selection: it all starts here.
    Strasberg SM
    Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S1-7. PubMed ID: 9377764
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of high aminotransferase levels on rejection in liver transplantation.
    Bao YM; Adam R; Samuel D; Castaing D; Bismuth H
    Transplant Proc; 1994 Feb; 26(1):259-60. PubMed ID: 8108967
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation pathology.
    Hübscher SG
    Semin Liver Dis; 2009 Feb; 29(1):74-90. PubMed ID: 19235661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reperfusion injury to donor livers stored for transplantation.
    Lemasters JJ; Bunzendahl H; Thurman RG
    Liver Transpl Surg; 1995 Mar; 1(2):124-38. PubMed ID: 9346554
    [No Abstract]   [Full Text] [Related]  

  • 5. Cold preservation mediated renal injury: involvement of mitochondrial oxidative stress.
    Saba H; Munusamy S; Macmillan-Crow LA
    Ren Fail; 2008; 30(2):125-33. PubMed ID: 18300110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation solutions in liver transplantation: what are the options?
    Eghtesad B; Aucejo F; Fung JJ
    Liver Transpl; 2006 Feb; 12(2):196-8. PubMed ID: 16447207
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological modulation of liver ischemia-reperfusion injury.
    de Rougemont O; Dutkowski P; Clavien PA
    Curr Opin Organ Transplant; 2010 Apr; 15(2):183-9. PubMed ID: 20125019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers.
    de Perrot M; Bonser RS; Dark J; Kelly RF; McGiffin D; Menza R; Pajaro O; Schueler S; Verleden GM;
    J Heart Lung Transplant; 2005 Oct; 24(10):1460-7. PubMed ID: 16210117
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney preservation: from 'do no further harm' to 'opportunity to recover'.
    van Heurn E
    Curr Opin Organ Transplant; 2011 Apr; 16(2):149-50. PubMed ID: 21415816
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation.
    Jiménez-Galanes S; Meneu-Diaz MJ; Elola-Olaso AM; Pérez-Saborido B; Yiliam FS; Calvo AG; Usera MA; González MC; González JC; González EM
    Liver Transpl; 2009 Sep; 15(9):1110-8. PubMed ID: 19718635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of donor brain death on renal function and arachidonic acid metabolism in a large animal model of hypothermic preservation injury.
    Mangino MJ; Kosieradzki M; Gilligan B; Woo H; Southard JH
    Transplantation; 2003 May; 75(10):1640-7. PubMed ID: 12777849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in organ preservation.
    Southard JH; Belzer FO
    Clin Transplant; 1993 Feb; 7(1 part 2):134-7. PubMed ID: 10148369
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention.
    Bzeizi KI; Jalan R; Plevris JN; Hayes PC
    Liver Transpl Surg; 1997 Mar; 3(2):137-48. PubMed ID: 9346727
    [No Abstract]   [Full Text] [Related]  

  • 14. The Emerging Importance of Liver Sinusoidal Endothelial Cells in Regulating Injury during Machine Perfusion of Deceased Liver Donors.
    Bhogal RH; Mergental H; Mirza DF; Afford SC
    Semin Liver Dis; 2018 Aug; 38(3):252-259. PubMed ID: 30041277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of preservation injury and prognostic value of reperfusion biopsy in outcome of liver transplantation.
    Bao YM; Adam R; Sebagh M; Reynes M; Bismuth H
    Transplant Proc; 1996 Feb; 28(1):123-5. PubMed ID: 8644141
    [No Abstract]   [Full Text] [Related]  

  • 16. Steatotic donor livers: Where is the risk-benefit maximized?
    Hamar M; Selzner M
    Liver Transpl; 2017 Oct; 23(S1):S34-S39. PubMed ID: 28734124
    [No Abstract]   [Full Text] [Related]  

  • 17. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways of regeneration and repair after liver transplantation.
    Olthoff KM
    World J Surg; 2002 Jul; 26(7):831-7. PubMed ID: 11948365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
    Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience.
    Grewal HP; Willingham DL; Nguyen J; Hewitt WR; Taner BC; Cornell D; Rosser BG; Keaveny AP; Aranda-Michel J; Satyanarayana R; Harnois D; Dickson RC; Kramer DJ; Hughes CB
    Liver Transpl; 2009 Sep; 15(9):1028-35. PubMed ID: 19718636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.